CRBU - Caribou Biosciences, Inc. Common Stock

Caribou Biosciences, Inc. (CRBU)

NGS · Common · CUSIP 142038108

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CRBU and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 142038108
Market Cap: Large Cap
IPO: 7/23/2021 · $16.00/share

Links: Home Page Investor Relations News

Business: Caribou Biosciences, Inc is a clinical-stage biopharmaceutical company, founded by pioneers in CRISPR genome editing, leveraging its proprietary technology to develop genome-edited off-the-shelf immune cell therapies for the treatment of cancer.

Company Contact

CEO: Rachel E. Haurwitz
CFO: Sri Ryali
Headquarters: 2929 7th Street, Suite 105, Berkeley, CA 94710
Phone: 510-982-6030
Investor Relations: Amy Figueroa · 510-982-6030 · afigueroa@cariboubio.com
General Email: info@cariboubio.com
Email Form: Contact Form »
SEC EDGAR Filings: View filings »